A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie

Updated on: February 23,2024

A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie

Updated on:February 23,2024

The hitchhiker's guide to defeating glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside

Updated on: April 18,2024

The hitchhiker's guide to defeating glioblastoma

by Brigham and Women's HospitalGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In cancer therapeutics research, microRNAs—tiny strings of nucleotides that get churned out inside

Updated on:April 18,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on: January 30,2024

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Updated on:January 30,2024

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on: January 30,2024

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on:January 30,2024

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith

Updated on: February 24,2024

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith

Updated on:February 24,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on: January 30,2024

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on:January 30,2024

Diverse immune cell profiles and roles found in breast cancer resistance to immunotherapy

by Baylor College of MedicineDr. Xiang 'Shawn' Zhang, the corresponding author of this work. Credit: Baylor College of MedicineIn recent years it has been increasingly appreciated that im

Updated on: April 22,2024

Diverse immune cell profiles and roles found in breast cancer resistance to immunotherapy

by Baylor College of MedicineDr. Xiang 'Shawn' Zhang, the corresponding author of this work. Credit: Baylor College of MedicineIn recent years it has been increasingly appreciated that im

Updated on:April 22,2024

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun

Updated on: May 25,2024

Doctors are being sexually harassed at work—this needs to stop

by Louise Stone,The ConversationCredit: Unsplash/CC0 Public DomainDominique Leewas training in radiation oncology when she was invited to join her supervisor to discuss a training opportun

Updated on:May 25,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on: February 01,2024

Researchers explore why patients don't follow up with their doctors after receiving a positive colorectal cancer test

by American Academy of Family PhysiciansReasons for no colonoscopy after an unfavorable screening result in Dutch colorectal cancer screening: a nation-wise questionnaire. Credit:The Annals

Updated on:February 01,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024